Quality of life issues in patients with bone metastases: A systematic review

Rajeswaran, Thenugaa; Wong, Henry C. Y.; Zhang, Elwyn; Kennedy, Samantha K. F.; Gojsevic, Milena; Soliman, Hany; Vassiliou, Vassilios; Rades, Dirk; Bonomo, Pierluigi; Lee, Shing-Fung; Chan, Adrian Wai; Rembielak, Agata; Oldenburger, Eva; Maranzano, Ernesto; Pergolizzi, Stefano; Finkelstein, Joel A.; Larouche, Jeremie; Zhang, Na; Zhang, Xiaojing; Marta, Gustavo N.; Yee, Albert J. M.; Yu, Shengji; van der Velden, Joanne M.; van der Linden, Yvette M.; Chow, Edward; ,

doi:10.1007/s00520-023-08241-0

Cited by 1 publication

(1 citation statement)

References 44 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Bone metastases disturb the intricate equilibrium between bone formation and resorption, which is mainly regulated by osteoblasts and osteoclasts. This disruption results in skeletal problems that have a substantial impact on patient morbidity and quality of life [3]. Bone metastases arise when cancer cells detach from the initial tumor, disseminate throughout the body, and form secondary tumors inside the bone tissue.…”

Section: Introductionmentioning

confidence: 99%

Intersecting Paths: Unraveling the Complex Journey of Cancer to Bone Metastasis

Arakil,

Akhund,

Elaasser

et al. 2024

Biomedicines

View full text Add to dashboard Cite

The phenomenon of bone metastases presents a significant challenge within the context of advanced cancer treatments, particularly pertaining to breast, prostate, and lung cancers. These metastatic occurrences stem from the dissemination of cancerous cells into the bone, thereby interrupting the equilibrium between osteoblasts and osteoclasts. Such disruption results in skeletal complications, adversely affecting patient morbidity and quality of life. This review discusses the intricate interplay between cancer cells and the bone microenvironment, positing the bone not merely as a passive recipient of metastatic cells but as an active contributor to cancer progression through its distinctive biochemical and cellular makeup. A thorough examination of bone structure and the dynamics of bone remodeling is undertaken, elucidating how metastatic cancer cells exploit these processes. This review explores the genetic and molecular pathways that underpin the onset and development of bone metastases. Particular emphasis is placed on the roles of cytokines and growth factors in facilitating osteoclastogenesis and influencing osteoblast activity. Additionally, this paper offers a meticulous critique of current diagnostic methodologies, ranging from conventional radiography to advanced molecular imaging techniques, and discusses the implications of a nuanced understanding of bone metastasis biology for therapeutic intervention. This includes the development of targeted therapies and strategies for managing bone pain and other skeletal-related events. Moreover, this review underscores the imperative of ongoing research efforts aimed at identifying novel therapeutic targets and refining management approaches for bone metastases. It advocates for a multidisciplinary strategy that integrates advancements in medical oncology and radiology with insights derived from molecular biology and genetics, to enhance prognostic outcomes and the quality of life for patients afflicted by this debilitating condition. In summary, bone metastases constitute a complex issue that demands a comprehensive and informed approach to treatment. This article contributes to the ongoing discourse by consolidating existing knowledge and identifying avenues for future investigation, with the overarching objective of ameliorating patient care in the domain of oncology.

show abstract

Section: Introductionmentioning

confidence: 99%